February 11, 2011 — In patients with severe spasticity related to multiple sclerosis (MS), intrathecal baclofen (ITB) using a programmable, subcutaneously implanted pump can be an effective ...
MS frequently results in impaired movement largely because of spasticity, difficulties with balance and coordination, tremor, and weakness. Every symptom that affects mobility has the potential to ...
Mount Olive, New Jersey-based Flowonix Medical Inc. said Wednesday that the United States Food and Drug Administration granted approval to market the Prometra II Programmable Pump System for use with ...
Researchers from Kessler Foundation and Kessler Institute for Rehabilitation (collectively "Kessler") conducted the first prospective study to assess whether transcutaneous spinal stimulation (TSS) ...
Study design: Case series of a consecutive sample. Retrospective audit. Objective: To analyze the long-term safety and efficacy of intrathecal baclofen (ITB), and technical incidents. Setting: ...
Kessler pilot study shows pump delivery system unaffected although interference with communication may occur during the pump’s log transmission The pilot study was conducted at the Tim and Caroline ...
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced the commercial launch of LYVISPAH ®, a baclofen oral granules (5, 10 and 20 mg) specialty product approved by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results